Immutep IMMP
NASDAQ IMMP
$3.13 -0.13 (-3.99%)
As of: Oct 22, 2026 · 11:48 AM EDT

Immutep (IMMP) EBITDA Margin (2014 - 2017)

Updated

Immutep (IMMP) recorded EBITDA Margin of -528.27% in the year ended Jun 30, 2026, up 43.60 percentage points from -571.87% a year earlier.

Analysis

Immutep (IMMP) EBITDA Margin (2014 - 2017) Analysis & Trends

Starting with the year ended Jun 30, 2010, Immutep's EBITDA Margin history includes 13 years.

  • Annual EBITDA Margin has a four-year change of +18432.47 percentage points (years ended Jun 2022 to Jun 2026).
  • The figure for the year ended Jun 30, 2026 is the highest annual EBITDA Margin since the year ended Jun 30, 2020.
  • Per Business Quant data, IMMP's EBITDA Margin was -571.87% in the year ended Jun 30, 2025 and -18960.74% in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,168.10 Bn 1,136.68 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 643.43 Bn 561.95 Bn 17.26 Bn 35.95%
3 AbbVie 500.92 Bn 474.03 Bn 12.70 Bn 49.01%
4 Merck 360.47 Bn 314.85 Bn 12.21 Bn 6.02%
5 Novartis Ag 302.41 Bn 266.40 Bn 11.24 Bn -
6 Astrazeneca 267.36 Bn 241.05 Bn 12.86 Bn 33.11%
7 Amgen 241.30 Bn 196.70 Bn 7.24 Bn 46.01%
8 Gilead Sciences 192.97 Bn 167.17 Bn 6.22 Bn -124.26%
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn 39.16%
10 Immutep 22.75 Mn -188.28 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 183.87%
Mar 31, 2017 -160.92%
Jun 30, 2016 3,421,600.76%
Mar 31, 2016 -894.17%
Jun 30, 2015 -18,838.90%
Jun 30, 2014 -80,677.40%
API Access

Immutep EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMMP&period=max&api_key=YOUR_API_KEY